Miguel Elias
Aguado Barrera
University of Milan
Milán, ItaliaPublicacións en colaboración con investigadores/as de University of Milan (8)
2023
-
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
Radiotherapy and Oncology, Vol. 178
2022
-
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
Frontiers in Oncology, Vol. 12
-
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort
eBioMedicine, Vol. 84
-
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
Radiotherapy and Oncology, Vol. 168, pp. 75-82
2021
-
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
Radiotherapy and Oncology, Vol. 159, pp. 241-248
2020
-
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort
Frontiers in Oncology, Vol. 10
-
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort
Frontiers in Oncology, Vol. 10
2019
-
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
Radiotherapy and Oncology, Vol. 138, pp. 59-67